Evidence map›Paper›PMID 32721530›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

Hospital-based surveillance for Japanese encephalitis in Bangladesh, 2007-2016: Implications for introduction of immunization.

Kishor Kumar Paul, Hossain M S Sazzad, Mahmudur Rahman, Sharmin Sultana, M Jahangir Hossain, Jeremy P Ledermann, Paul Burns, Michael S Friedman, Meerjady S Flora, Marc Fischer and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Knowledge, Attitudes, and Practices in Relation to Mosquito-Borne Diseases in Bangladesh.International journal of environmental research and public health · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Kishor Kumar PaulInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh; The Kirby Institute, University of New South Wales, Sydney, Australia. Electronic address: Kpaul@kirby.unsw.edu.au.
Hossain M S SazzadInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh; The Kirby Institute, University of New South Wales, Sydney, Australia.
Mahmudur RahmanInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Sharmin SultanaInstitute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.
M Jahangir HossainInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, Gambia.
Jeremy P LedermannArboviral Diseases Branch, Centers for Disease Control and Prevention (CDC), Fort Collins, CO, USA.
Paul BurnsArboviral Diseases Branch, Centers for Disease Control and Prevention (CDC), Fort Collins, CO, USA.
Michael S FriedmanCDC, Country Office for Bangladesh, Dhaka, Bangladesh.
Meerjady S FloraInstitute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.
Marc FischerArboviral Diseases Branch, Centers for Disease Control and Prevention (CDC), Fort Collins, CO, USA.
Susan HillsArboviral Diseases Branch, Centers for Disease Control and Prevention (CDC), Fort Collins, CO, USA.
Stephen P LubyStanford University, Stanford, CA, USA.
Emily S GurleyJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Centers for Disease Control and Prevention · USInternational Centre for Diarrhoeal Disease Research · BDInstitute of Epidemiology, Disease Control and Research · BDJohns Hopkins University · USMRC Unit the Gambia · GMStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJapanese encephalitis (JE) virus is recognized as a major cause of encephalitis in Bangladesh. The World Health Organization (WHO) recommends human immunization as the most effective means to control JE. Several WHO-prequalified vaccines are available to prevent JE but no vaccination program has been implemented in Bangladesh.

methodsWe conducted hospital-based surveillance for acute meningitis-encephalitis syndrome (AMES) to describe JE epidemiology and help inform policy decisions about possible immunization strategies for Bangladesh.

resultsDuring 2007-2016, a total of 6543 AMES patients were identified at four tertiary hospitals. Of the 6525 patients tested, 548 (8%) were classified as JE cases. These 548 patients resided in 36 (56%) out of 64 districts of Bangladesh, with the highest proportion of JE cases among AMES patients (12% and 7%) presenting at two hospitals in the northwestern part of the country. The median age of JE cases was 30 years, and 193 (35%) were aged ≤15 years. The majority of JE cases (80%) were identified from July through November.

conclusionsSurveillance results suggest that JE continues to be an important cause of meningo-encephalitis in Bangladesh. Immunization strategies including JE vaccine introduction into the routine childhood immunization program or mass vaccination in certain age groups or geographic areas need to be examined, taking into consideration the cost-effectiveness ratio of the approach and potential for decreasing disease burden.

Indexed as

Acute Febrile EncephalopathyAdolescentAdultAgedBangladeshChildChild, PreschoolCost-Benefit AnalysisCost of IllnessEncephalitis, JapaneseEpidemiological MonitoringFemaleHumansJapanese Encephalitis VaccinesMaleMass VaccinationJapanese Encephalitis VaccinesCauses of encephalitisHospital-based surveillanceJapanese encephalitisVaccinationVaccine-preventable disease

Identifiers

PMID32721530
PMCPMC7566160
OpenAlexW3045438580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.